SHANGHAI – October 28, 2026 -- Jiahui International Hospital has launched the Jiahui International Cell Therapy Center to treat CAR-T patients from China and abroad, citing rising international demand. The hospital handles nearly 500,000 patient visits a year from 180 countries and regions.

Center unveiled at inaugural summit with viewers from 14 countries

The center was introduced on October 23 at the first Jiahui International Cell Therapy Summit. Jiahui International Hospital hosted the event, and Jiahui Medical Research & Education Group (J-Med) co-organized it. Livestream viewing registrations came from 14 countries and regions.

Prof. HAO Siguo, Chief of Hematology at Jiahui International Cancer Center (JICC), and Prof. XUAN Linli, Chief of Medical Oncology at JICC, joined experts discussing cellular therapies for blood cancers, solid tumors and autoimmune diseases.

JICC treated China's first international Axi-Cel patient in September 2023

That patient, a Singaporean woman with primary mediastinal large B-cell lymphoma, has remained relapse-free for more than three years. JICC has since provided CAR-T treatment to patients from Singapore, Hong Kong SAR, Russia, Hungary, New Zealand, India, Pakistan, the Maldives and other countries and regions.

Jiahui treats world's first international Satri-cel recipient after June 2026 approval

China approved Satri-cel (CT041) in June 2026 as the world's first CAR-T therapy cleared for solid tumors. Jiahui became one of the first institutions to introduce it clinically. Its first international recipient was a 59-year-old New Zealand patient with advanced gastroduodenal cancer.

NEJM editor cites rise in Chinese research output to more than 20 articles

Eric J. Rubin, Editor-in-Chief of the New England Journal of Medicine, said the journal published one research article by Chinese scholars a decade ago, compared with more than 20 in 2026. Prof. John K. HSIANG, Chairman of the Jiahui Health Executive Committee, highlighted China's advances in medical innovation.

Prof. Allen WU, President of Jiahui International Hospital, said the center will link research and clinical care through multidisciplinary expertise and international patient services.